Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,234 | -$21,006 | -$19,680 | -$22,831 |
| Dep. & Amort. | $300 | $162 | $311 | $303 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,927 | $3,791 | $3,707 |
| Change in WC | $1,466 | $52 | -$3,845 | $2,115 |
| Other Non-Cash | $4,185 | $255 | -$112 | -$654 |
| Operating Cash Flow | -$12,283 | -$16,610 | -$19,535 | -$17,360 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$899 | -$493 | -$58 | -$827 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$33,190 | -$15,056 | -$20,228 | -$34,761 |
| Inv. Sales/Matur. | $40,000 | $35,000 | $39,500 | $50,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $5,911 | $19,451 | $19,214 | $14,412 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$117 | -$97 | -$344 | -$647 |
| Financing Cash Flow | -$117 | -$97 | -$343 | -$647 |
| Forex Effect | -$1 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,490 | $2,744 | -$664 | -$3,595 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,895 | $39,352 | $40,016 | $43,611 |
| End Cash | $35,405 | $42,096 | $39,352 | $40,016 |
| Free Cash Flow | -$13,182 | -$17,103 | -$19,593 | -$18,187 |